Sign In
Buy PLRX
$1.18
+0.0200 (+1.72%)
At Close: Jun 03, 2026
Pliant Therapeutics, Inc. (PLRX) Expected to Beat Earnings Estimates: Should You Buy?
02:01pm, Monday, 01'st Aug 2022 Zacks Investment Research
Pliant Therapeutics, Inc. (PLRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How Much Upside is Left in Pliant Therapeutics, Inc. (PLRX)? Wall Street Analysts Think 142%
01:55pm, Thursday, 28'th Jul 2022 Zacks Investment Research
The consensus price target hints at a 142.4% upside potential for Pliant Therapeutics, Inc. (PLRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in
2022 Roundtable: Our Favorite Picks Right Now
02:00pm, Sunday, 24'th Jul 2022 The Motley Fool
Here's why we like Novavax, Orthopediatrics, and Pliant Therapeutics.
2022 Roundtable: Our Favorite Picks Right Now
10:00am, Sunday, 24'th Jul 2022
Here's why we like Novavax, Orthopediatrics, and Pliant Therapeutics.
4 Analysts Have This to Say About Pliant Therapeutics
04:05pm, Wednesday, 20'th Jul 2022 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Pliant Therapeutics (NASDAQ:PLRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understandi
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
02:10pm, Wednesday, 20'th Jul 2022 Benzinga
Upgrades
B of A Securities upgraded the previous rating for Check Point Software Technologies Ltd (NASDAQ:CHKP) from Underperform to Buy. Check Point Software earned $1.57 in the first quarter, compar
Could Pliant Therapeutics Stock Double Your Money?
03:30pm, Monday, 18'th Jul 2022 The Motley Fool
Wall Street thinks this red-hot biotech stock has a lot more room to run.
Boeing, PriceSmart And 80 Biggest Movers From Yesterday
08:59am, Wednesday, 13'th Jul 2022 Benzinga
Gainers
Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.
Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session
04:00pm, Tuesday, 12'th Jul 2022 Benzinga
Gainers
Canoo Inc. (NASDAQ: GOEV) shares jumped 79.9% to $4.2627 after Walmart signed a definitive agreement with the company to purchase 4,500 all-electric delivery vehicles, beginning with the Life
Pliant Therapeutics (PLRX) Up on Positive Data From Lung Disease Study
03:01pm, Tuesday, 12'th Jul 2022 Zacks Investment Research
Pliant Therapeutics (PLRX) reports favorable data from a mid-stage study, which supports the potential of PLN-74809, its experimental drug candidate for treating IPF.
Pliant Therapeutics (PLRX) Up on Positive Data From Lung Disease Study
12:20pm, Tuesday, 12'th Jul 2022
Pliant Therapeutics (PLRX) reports favorable data from a mid-stage study, which supports the potential of PLN-74809, its experimental drug candidate for treating IPF.
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
09:35am, Tuesday, 12'th Jul 2022 Benzinga
Gainers
Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
Pliant Therapeutics, Inc. (NASDAQ: PLRX) sha
What's Going On With Pliant Therapeutics Stock?
08:47am, Tuesday, 12'th Jul 2022
Pliant Therapeutics Inc (NASDAQ: PLRX) shares are trading lower Tuesday after the company announced a proposed $150 million offering. Pliant Therapeutics shares soared by nearly 160% Monday on th
Pliant Therapeutics, Inc. (PLRX) Stock Jumps 159%: Will It Continue to Soar?
08:35am, Tuesday, 12'th Jul 2022 Zacks Investment Research
Pliant Therapeutics, Inc. (PLRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further str
Pliant Therapeutics, Inc. (PLRX) Stock Jumps 159%: Will It Continue to Soar?
06:12am, Tuesday, 12'th Jul 2022
Pliant Therapeutics, Inc. (PLRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further str
